DEVICES ADVISORY COMMITEE TO MEET MAY 23

FDA's Radiological Devices Panel of the Medical Devices Advisory Committee will meet on May 23 to make recommendations on the reclassification of digital mammography systems from Class III to Class II devices, following an FDA presentation.

At the meeting, to be held at the Holiday Inn in Gaithersburg, Md., the advisory committee will also hear a presentation on the Critical Path initiative.

Additionally, the Center for Devices and Radiological Health's Office of Surveillance and Biometrics will outline its plan for the review of postmarket study designs.